Evolva
Reinach
About Evolva
Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients. Evolva was founded in 2004 around a distinctive, proprietary, technology platform that uses synthetic biology to create innovative small-molecule drugs and other compounds. In particular, their platform allows the creation of chemistries that recapitulate the themes found in natural products, but without the disadvantages of those approaches. The company is headquartered in Reinach, Switzerland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $109.8M
- Funding stage: M&A
- Last round: Grant (Oct 2022)
- Ticker: swx:EVE
- Website: evolva.com
- Phone: 41 61 485 20 00
Industries & Categories
Biotechnology, Food and Beverage, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/evolva-146203 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.